VENUS REMEDIES
|
The Current P/E Ratio of VENUS REMEDIES is 19.19.
Share Price | ₹316.4 | Dec 02,2024 |
Market Cap | ₹424.0 Cr | |
Earnings-TTM | ₹22.1 Cr | TTM-Consolidated Results |
Price/Earnings | 19.19x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹424.0 Cr] as on Dec 02,2024
(/) Earnings [ ₹22.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 19.19x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay 19.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES
PE Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.55x.
- VENUS REMEDIES 's operated at median p/e ratio of 8.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 15.31x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VENUS REMEDIES | 22.09 | 19.19 | 424.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.96 | 433,848.0 |
CIPLA LTD | 4,485.22 | 27.15 | 121,796.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.85 | 101,919.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.81 | 98,072.6 |
DIVIS LABORATORIES LTD | 1,836.00 | 90.37 | 165,923.0 |
MANKIND PHARMA LTD | 2,124.86 | 49.31 | 104,785.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 62.70 | 112,987.0 |
LUPIN LTD | 2,651.94 | 35.60 | 94,407.8 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.26 | 72,905.1 |
ABBOTT INDIA LTD | 1,284.66 | 46.41 | 59,617.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.85x |
Max industry PE | 90.37x |
Median industry PE | 35.60x |
Average industry PE | 39.24x |
You may also like the below Video Courses